Preprints: Why and how to use them.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 104, doi. 10.56012/nwco8539
- By:
- Publication type:
- Article
Works matching IS 20474806 AND DT 2024 AND VI 33 AND IP 3
Results: 31
1
2
Journal errata.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 10
- Publication type:
- Article
3
Results section of a journal article.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 112, doi. 10.56012/rpfd6138
- By:
- Publication type:
- Article
4
The virologists in the reusable masks.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 108, doi. 10.56012/fusu7803
- By:
- Publication type:
- Article
5
The Crofter: Sustainable Communications.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 108
- By:
- Publication type:
- Article
6
Guide to the De-Identification of Personal Health Information.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 102, doi. 10.56012/hbvt6966
- By:
- Publication type:
- Article
7
Regulatory Public Disclosure.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 95, doi. 10.56012/vhdv1639
- By:
- Publication type:
- Article
8
Involving patients in company-sponsored medical publications: Learning from collaboration with a patient advocacy group to engage patient authors.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 89, doi. 10.56012/rowv7554
- By:
- Publication type:
- Article
9
Medical Communications and Writing for Patients.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 89
- By:
- Publication type:
- Article
10
Exploring the role of Microsoft's Copilot in visual communication: Current use and considerations through science communicators' lens.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 79, doi. 10.56012/pacl5831
- By:
- Publication type:
- Article
11
Digital Communication.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 79
- By:
- Publication type:
- Article
12
EMA supports pilot for joint African continental assessment procedures.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 78
- Publication type:
- Article
13
First nasal adrenaline spray for emergency treatment against allergic reactions.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 77
- Publication type:
- Article
14
Positive CHMP opinion on first-in-class medicine to treat pulmonary arterial hypertension.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 76
- Publication type:
- Article
15
Faster access to clinical trial information in Europe.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 75
- Publication type:
- Article
16
First vaccine to protect adults from Chikungunya.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 74
- Publication type:
- Article
17
Medical devices: New guidance for industry and notified bodies.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 73
- Publication type:
- Article
18
European medicines network designated as WHO Listed Authority.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 73
- Publication type:
- Article
19
One Health: a joint framework for action published by five EU agencies.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 72
- Publication type:
- Article
20
Medical writing in Italy in 2024: Results of the first Italian business and compensation survey.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 62, doi. 10.56012/zgzn6726
- By:
- Publication type:
- Article
21
Navigating the complex landscape of clinical trial transparency: What medical writers need to know.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 26, doi. 10.56012/timm8993
- By:
- Publication type:
- Article
22
Creating educational materials about clinical research data for patients and the public: A multifaceted journey in the current digital age.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 46, doi. 10.56012/gyeg6536
- By:
- Publication type:
- Article
23
The 2023 CORE Reference Utility Survey: Perceptions on a best practice tool for globally applicable clinical study reporting and provision of continuing professional development resources for the regulatory medical writing community.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 38, doi. 10.56012/rnqo6114
- By:
- Publication type:
- Article
24
Plain language summaries of clinical trial results: What is their role, and should patients and AI be involved?
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 34, doi. 10.56012/yayy4394
- By:
- Publication type:
- Article
25
Publisher perspectives on plain language summaries of scientific publications: An Open Pharma survey.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 54, doi. 10.56012/pzwh6593
- By:
- Publication type:
- Article
26
Protection of personal data and commercially confidential information under the Clinical Trials Regulation (EU) No 536/2014: EMA "Revised CTIS Transparency Rules".
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 12, doi. 10.56012/frkj6889
- By:
- Publication type:
- Article
27
Local hubs for the virtual November conference.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 10, doi. 10.56012/imbl5235
- By:
- Publication type:
- Article
28
Navigating the new era of clinical trial transparency.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 8, doi. 10.56012/ofqn1420
- By:
- Publication type:
- Article
29
The clinical research transparency journey.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 6, doi. 10.56012/djjd9152
- By:
- Publication type:
- Article
30
Making the leap: Transparency requirements for clinical trials moving from one regulatory framework to another.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 22, doi. 10.56012/ghkj9468
- By:
- Publication type:
- Article
31
Clinical trial transparency and disclosure from the medical writing perspective.
- Published in:
- Medical Writing, 2024, v. 33, n. 3, p. 2, doi. 10.56012/gkvo3717
- By:
- Publication type:
- Article